POSTER SESSION III
Tuesday, March 23, 2010 — 9:30 AM - 12:00 Noon
Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
PULMONARY PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
247
Detection of Circulating Tumor Cells in Patients Undergoing Surgery for Non-Small Cell Lung Cancer. A Pilot Study Comparing an Indirect Technique, the CellSearch System, and a Cytomorphological Approach, the Isolation by Size of Epithelial Tumor Cells Method
(1803)
V Hofman, E Long, M Ilie, E Selva, C Bonnetaud, V Lespinet, T Molina, P Viehl, S Lantuejoul, J Mouroux, P Paterlini-Brechot, P Hofman - CHU Nice, Nice, France; Hotel Dieu, Paris, France; IGR, Paris, France; CHU Michallon, Grenoble, France; Universite ParisV, Paris, France
Evaluation of miRNAs Levels of p53 Pathways in Non Small Cell Lung Cancer
(1840)
J Ramirez, A Navarro, A Quera, T Diaz, A Huerta, N Vinolas, M Monzo, R Marrades - Hospital Clinic, IDIBAPS, CIBERES,Universitat de Barcelona, Barcelona, Spain; Universitat de Barcelona, Barcelona, Spain; Hospital Clinic, IDIBAPS, CIBERES, Barcelona, Spain
Prognostic microRNA Signature in Early Stage Lung Adenorcarcinomas: Preliminary Results
(1834)
C Ortholan, V Hofman, C Bonnetaud, O Bordonne, M Ilie, V Virolle, T Virolle, N Venissac, J Mouroux, P Barbry, B Mari, P Hofman - CHU, Nice, France; INSERM, Nice, France; CNRS UMR6097, Nice, France
Cyclooxygenase-2 Overexpression Is Linked to Increased VEGFR-3 Levels in Lung Adenocarcinoma but Its Association with Survival Is of Borderline Significance
(1844)
S Sethi, F Lonardo - Karmanos Cancer Center, Wayne State University and The Detroit Medical Center, Detroit, MI
Sox2 Protein Expression Is an Independent Poor Prognostic Indicator in Stage I Lung Adenocarcinomas
(1846)
LM Sholl, JA Barletta, LR Chirieac, JL Hornick - Brigham and Women's Hospital, Boston, MA
SOX2 Amplification Is a Frequent Event in Squamous Cell Lung Cancer
(1855)
T Wilbertz, P Wagner, AC Stiedl, K Petersen, V Scheble, H Moch, NK Altorki, A Soltermann, S Perner - University Hospital Tuebingen, Tuebingen, Germany; New York Hospital/Weill Cornell Medical Center, New York, NY; University Hospital Zurich, Zurich, Switzerland
Immunohistochemistry with Mutation Specific Antibodies Detecting the Status of EGFR Mutations in Non-Small-Cell Lung Cancer
(1818)
D Li, S Chen, C Hu, Y Lei, J Yu - Second Xiangya Hospital, Central South University, Changsha, China; Hunan Cancer Hospital, Changsha, China; Second Xiangya Hospital, Changsha, China; Hunan Province People's Hospital, Changsha, China; Cell Signaling Technology, Danvers, MA
Associations of C-MET Gene copy with EGFR Mutation and Gene Copy in EGFR-Tyrosine Kinase Inhibitor Untreated Non-Small Cell Lung Cancer
(1773)
JM Bae, YK Jeon, YT Kim, JW Seo, YA Kim, DH Chung - Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea; Seoul City Boramae Hospital, Seoul, Korea
EGFR and KRAS Mutations in Non-Small Cell Lung Cancers: A Pilot Study from Turkey
(1777)
S Bircan, H Baloglu, Z Kucukodaci, A Bircan - Suleyman Demirel University Faculty of Medicine, Isparta, Turkey; Gulhane Medical Academy Haydarpasa Teaching Hospital, Istanbul, Turkey
Occurrence and Frequency of Heterogeneity in EGFR Immunohistochemical Expression in Lung Adenocarcinomas of Mixed Type - Possible Consequences for EGFR Predictive Testing
(1831)
JR Nilsson, C Lindh, S Fanunza, S Ahlberg, G Elmberger - Karolinska Hospital, Stockholm, Sweden
KRAS Amplification in Non-Small Cell Lung Carcinoma
(1851)
AC Stiedl, PL Wagner, T Wilbertz, NK Altorki, SR Perner - Universtiy Hospital of Tuebingen, Tuebingen, Germany; New York Hospital/Weill Cornell Medical Center, New York, NY
Mutational Profiling of Non-Small Cell Lung Cancer by Sequenom's OncoCarta™ Panel
(1813)
DM Kohler, T John, M Tsao - University Health Network and Princess Margaret Hospital and University of Toronto, Toronto, ON, Canada
Mutational Analysis of EGFR, KRAS, BRAF, PIK3CA and ERBB2 in Non-Small-Cell Lung Carcinomas
(1783)
L Cheng, PA Janne, DM Jackman, BE Johnson, VA Joshi, NI Lindeman - Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Laboratory for Molecular Medicine, Harvard Medical School, Cambridge, MA
Molecular Profiles of EGFR and KRAS Mutations in Non-Small-Cell Lung Carcinoma: A Survey of 344 Cases
(1782)
SS Chen, R Luthra, LJ Medeiros, Z Zuo - University of Texas MD Anderson Cancer Center, Houston, TX
ERCC1,VEGFR, NF-kB and Gender in Chemotherapy-Treated Advanced Stage NSCLC: An Ongoing Study Report
(1850)
A Somoza, HX Bui, N Patil, P Pathrose, A Mostafa, MB Rao, M Anderson, N Abdel Karim - VA Medical Center, Cincinnati, OH; University of Cincinnati, Cincinnati, OH
Expression of hMLH1 and hMSH2 Proteins in Non-Small Cell Lung Cancer and Its Clinicopathologic Significance - From the Viewpoint of Forthcoming New TNM Classification
(1784)
JY Choe, KB Lee, HJ Lee, XH Xu, JH Chung - Seoul National University Bundang Hospital, Seongnam, Korea; Seoul National University College of Medicine, Seoul, Korea
button next to any title to add to Itinerary Planner...
Add
